{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:23:03Z","timestamp":1792088583749,"version":"4.4.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Reumafonds","award":["10-1-413"],"award-info":[{"award-number":["10-1-413"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0171070","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T18:52:26Z","timestamp":1486061546000},"page":"e0171070","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?"],"prefix":"10.1371","volume":"12","author":[{"given":"Annelieke","family":"Pasma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier","family":"Timman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"van \u2018t Spijker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathelijne","family":"Appels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willemijn H.","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Goekoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M. W.","family":"Hazes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J. V.","family":"Busschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2012.12.001","article-title":"Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: A systematic review","volume":"43","author":"A Pasma","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/eci.12.23","article-title":"Medication adherence in patients with rheumatoid arthritis: A critical appraisal of the existing literature","volume":"8","author":"BJF Van Den Bemt","year":"2012","journal-title":"Expert Rev Clin Immunol"},{"key":"ref3","unstructured":"Poos M, Bijenhof A, Slobbe L. Reumato\u00efde artritis (RA): Hoeveel zorg gebruiken pati\u00ebnten en wat zijn de kosten?. Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid, versie 4.17 2014 23 june 2014 [cited; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nationaalkompas.nl\/gezondheid-en-ziekte\/ziekten-en-aandoeningen\/bewegingsstelsel-en-bindweefsel\/reumatoide-artritis-ra\/zorgkosten\/\" xlink:type=\"simple\">http:\/\/www.nationaalkompas.nl\/gezondheid-en-ziekte\/ziekten-en-aandoeningen\/bewegingsstelsel-en-bindweefsel\/reumatoide-artritis-ra\/zorgkosten\/<\/ext-link>"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.2003.014340","article-title":"Determinants of direct costs in Dutch rheumatoid arthritis patients","volume":"63","author":"SMM Verstappen","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"MC Sokol","year":"2005","journal-title":"Med Care"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"JS Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"J Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"SUPPL. 6","key":"ref8","first-page":"vi37","article-title":"Overview of safety of non-biologic and biologic DMARDs","volume":"51","author":"EM Ruderman","year":"2012","journal-title":"Rheumatology (United Kingdom)"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005650-200209000-00009","article-title":"Patient adherence and medical treatment outcomes A meta-analysis","volume":"40","author":"M Robin Dimatteo","year":"2002","journal-title":"Med Care"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3111\/13696998.2011.597808","article-title":"Pharmacoeconomic aspects of poor adherence: Can better adherence reduce healthcare costs?","volume":"14","author":"A Golay","year":"2011","journal-title":"J Med Econ"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients&apos; adherence to medical recommendations: A quantitative review of 50 years of research","volume":"42","author":"MR DiMatteo","year":"2004","journal-title":"Med Care"},{"issue":"11","key":"ref12","first-page":"18","article-title":"Evidence-based strategies to foster adherence and improve patient outcomes","volume":"17","author":"MR DiMatteo","year":"2004","journal-title":"JAAPA"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s10620-007-9968-0","article-title":"Medication non-adherence is associated with increased medical health care costs","volume":"53","author":"S Kane","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3899\/jrheum.140693","article-title":"Facilitators and barriers to adherence in the initiation phase of disease-modifying antirheumatic drug (DMARD) use in patients with arthritis who recently started their first DMARD treatment","volume":"42","author":"A Pasma","year":"2015","journal-title":"J Rheum"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0033291796004382","article-title":"A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects","volume":"27","author":"P Spinhoven","year":"1997","journal-title":"Psychol Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/ard.2006.059451","article-title":"Consensus Dutch Health Assessment Questionnaire","volume":"66","author":"M Boers","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref17","article-title":"Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg","author":"L Hakkaart-van Roijen","year":"2010"},{"key":"ref18","article-title":"Tarieflijst Instellingen 2012, supplement 2","year":"2011"},{"key":"ref19","unstructured":"Medicijnkosten. 2014 1 october 2014 [cited 2014 22 october]; Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.medicijnkosten.nl\" xlink:type=\"simple\">http:\/\/www.medicijnkosten.nl<\/ext-link>"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.3899\/jrheum.140306","article-title":"Inconsistent treatment with disease-modifying antirheumatic drugs: A longitudinal data analysis","volume":"41","author":"MD Mjaavatten","year":"2014","journal-title":"J Rheum"},{"issue":"7","key":"ref21","first-page":"1511","article-title":"Chronic comorbidity in patients with early rheumatoid arthritis: A descriptive study","volume":"28","author":"Van Gestel AM Kroot EJJA","year":"2001","journal-title":"J Rheum"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"L Osterberg","year":"2005","journal-title":"NEJM"},{"key":"ref23","first-page":"35","article-title":"Adherence and health care costs","volume":"7","author":"AO Iuga","year":"2014","journal-title":"Risk Manag Healthc Policy"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-9-111","article-title":"A retrospective study on the impact of comorbid depression or anxiety on healthcare resource use and costs among diabetic neuropathy patients","volume":"9","author":"L Boulanger","year":"2009","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jagp.2012.12.016","article-title":"The excess healthcare costs associated with depression and anxiety in elderly living in the community","volume":"21","author":"HM Vasiliadis","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.54.6.455","article-title":"Work disability in early rheumatoid arthritis","volume":"54","author":"D Doeglas","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/rheumatology\/37.8.837","article-title":"Direct cost of rheumatoid arthritis during the first six years: A cost-of-illness study","volume":"37","author":"CHM Van Jaarsveld","year":"1998","journal-title":"Brit J Rheumatol"},{"issue":"10","key":"ref28","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/art.24104","article-title":"Work and sick leave among patients with early inflammatory joint conditions","volume":"59","author":"GA Geuskens","year":"2008","journal-title":"Arthritis Care Res"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.yebeh.2008.03.009","article-title":"Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: Survey of patients with epilepsy and physicians","volume":"13","author":"CA Hovinga","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"4","key":"ref30","first-page":"e88","article-title":"Impact of medication adherence on work productivity in hypertension","volume":"4","author":"S Wagner","year":"2012","journal-title":"Am J Pharm Benefits"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0895-4356(88)90124-2","article-title":"The total cost of care and the use of pharmaceuticals in the management of rheumatoid arthritis: The medi-cal program","volume":"41","author":"J Jacobs","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"ref32","first-page":"1","article-title":"Does Electronic Monitoring Influence Adherence to Medication? Randomized Controlled Trial of Measurement Reactivity","author":"S Sutton","year":"2014","journal-title":"Ann Behav Med"},{"issue":"7557","key":"ref33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"SH Simpson","year":"2006","journal-title":"BMJ"},{"issue":"18","key":"ref34","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM198010303031804","article-title":"Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project","volume":"303","author":"PL Canner","year":"1980","journal-title":"NEJM"},{"issue":"15","key":"ref35","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","article-title":"Statin adherence and risk of accidents a cautionary tale","volume":"119","author":"CR Dormuth","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MLR.0b013e31819a5acc","article-title":"Physician communication and patient adherence to treatment: A meta-analysis","volume":"47","author":"KB Haskard Zolnierek","year":"2009","journal-title":"Med Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0171070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T09:16:37Z","timestamp":1658567797000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0171070"}},"subtitle":[],"editor":[{"given":"Jessica Myers","family":"Franklin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0171070","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}